According to a recent survey, hereditary angioedema is a rare genetic disorder that affects approximately 1 in 50,000 people worldwide. It is characterized by recurrent episodes of swelling in the skin and mucous membranes, which can be painful and potentially life-threatening if they occur in the airways or digestive tract. The condition results from a deficiency or dysfunction of C1 inhibitor protein, which regulates immune system activity and prevents excess fluid from leaking out of blood vessels into surrounding tissues. Symptoms may first appear during childhood or adolescence and often worsen over time without proper treatment. There are currently several medications available to prevent attacks or treat acute symptoms, including plasma-derived C1 inhibitor replacement therapy, bradykinin receptor antagonists, and kallikrein inhibitors. However, many patients still struggle to obtain prompt diagnosis and access to these treatments due to limited awareness among healthcare providers and high costs associated with their use. Ongoing research efforts are focused on improving diagnostic accuracy, developing new therapies with longer duration of action or better tolerability profiles than existing options, and exploring potential links between hereditary angioedema and other inflammatory conditions such as autoimmune disease or cancer.
1.
Waiting for a Sharp Increase in Prostate Cancer Cases.
2.
The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.
3.
Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.
4.
Which Risk Model Better Identifies High-Risk Smoldering MM?
5.
Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.
1.
The Danger of Methemoglobinemia and How to Prevent It
2.
Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment
3.
Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment
4.
Everything You Need to Know About Normal Potassium Levels
5.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
4.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation